Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft

Journal of Gastroenterology

Volumn 47, Issue 4, 2012, Pages 486-488

  Aoki, Taku ^a   Sugawara, Yasuhiko ^a   Takahashi, Michiro ^a   Kawaguchi, Yoshikuni ^a   Kaneko, Junichi ^a   Yamashiki, Noriyo ^a   Tamura, Sumihito ^a   Hasegawa, Kiyoshi ^a   Takahashi, Kouki ^b   Kokudo, Norihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anti CD25 antibody; Living donor; Lymphocytotoxic crossmatch

Indexed keywords

BASILIXIMAB; ENTECAVIR; HLA ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CASE REPORT; CATHETER INFECTION; DESENSITIZATION; DRUG INFUSION; END STAGE LIVER DISEASE; FEMALE; GRAFT SURVIVAL; HEPATITIS B; HLA TYPING; HUMAN; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOCYTE TYPING; PATIENT REFERRAL; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SPLENECTOMY; T LYMPHOCYTOTOXIC CROSSMATCH TITER;

ADULT; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; DESENSITIZATION, IMMUNOLOGIC; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; PLASMAPHERESIS; POSTOPERATIVE COMPLICATIONS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84863090239     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-012-0530-2     Document Type: Article

References (9)

1. Vo AA, Lukovsky M, Toyoda M, Wang J, Reinsmoen NL, Lai CH, et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med. 2008;359:242-51. (Pubitemid 352008439)
2. Bathgate AJ, McColl M, Garden OJ, Forsythe JL, Madhavan KK, Hayes PC. The effect of a positive T-lymphocytotoxic crossmatch on hepatic allograft survival and rejection. Liver Transpl Surg. 1998;4:280-4. (Pubitemid 28323747)
3. Matinlauri IH, Höckerstedt KA, Isoniemi HM. Equal overall rejection rate in pretransplant flow-cytometric cross-match negative and positive adult recipients in liver transplantation. Clin Transplant. 2005;19:626-31. (Pubitemid 41341694)
4. Muro M, Marin L, Miras M, Moya-Quiles R, Minguela A, Sánchez-Bueno F, et al. Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre. Transpl Immunol. 2005;14:91-7. (Pubitemid 40791124)
5. Sugawara Y, Tamura S, Kaneko J, Togashi J, Makuuchi M, Kokudo N. Postive lymphocytotoxic crossmatch does not adversely affect survival in living donor liver transplantation. Dig Surg. 2009;26:482-6.
6. Hori T, Uemoto S, Takada Y, Oike F, Ogura Y, Ogawa K, et al. Does a positive lymphocyte cross-match contraindicate livingdonor liver transplantation? Surgery. 2010;147:840-4.
7. Suh KS, Kim SB, Chang SH, Kim SH, Minn KW, Park MH, et al. Significance of positive cytotoxic cross-match in adult-to-adult living donor liver transplantation using small graft volume. Liver Transpl. 2002;8:1109-13. (Pubitemid 35469870)
8. Egawa H, Ohmori K, Haga H, Tsuji H, Yurugi K, Miyagawa-Hayashino A, et al. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation. Liver Transpl. 2007;13:579-88. (Pubitemid 46605862)
9. Ikegami T, Shirabe K, Soejima Y, Taketomi A, Maehara Y. Feasibility of ABO-incompatible living donor liver transplantation in the rituximab era. Liver Transpl. 2010;16:1332-3.